Clinical trials
Phase 1/2 trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Terminated | 6 |
| Recruiting | 6 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| AstraZeneca | 2 |
| Kartos Therapeutics, Inc. | 2 |
| NanoCarrier Co., Ltd. | 2 |
| Pfizer | 2 |
| Ablynx, a Sanofi company | 1 |
| Astellas Pharma Europe B.V. | 1 |
| Astria Therapeutics, Inc. | 1 |
| Bayer | 1 |
| Boston Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 6 |
| Colorectal Neoplasms | 3 |
| Hemophilia A | 3 |
| Hemophilia B | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Liver Cirrhosis | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Primary Myelofibrosis | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.